Brian M. Culley, President and CEO at Lineage Cell Therapeutics, Inc. (LCTX), bought 5,250 shares at $1.38 ($7K) on 2022-03-25, disclosed to the SEC on 2022-03-28.
Open-market purchase of $7k LCTX by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| LCTX | BUY | 2024-05-28 | $11K | — | Filing → |
| LCTX | BUY | 2022-04-04 | $10K | — | Filing → |
| LCTX | SELL | 2021-06-30 | $1.3M | — | Filing → |